These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Go CY; Mackay MT; Weiss SK; Stephens D; Adams-Webber T; Ashwal S; Snead OC; ; Neurology; 2012 Jun; 78(24):1974-80. PubMed ID: 22689735 [TBL] [Abstract][Full Text] [Related]
7. Infantile Spasms-Have We Made Progress? Kelley SA; Knupp KG Curr Neurol Neurosci Rep; 2018 Apr; 18(5):27. PubMed ID: 29671077 [TBL] [Abstract][Full Text] [Related]
8. Knowledge, Attitude and Practice (KAP) Study of Pediatricians on Infantile Spasms. Vaddi VK; Sahu JK; Dhawan SR; Suthar R; Sankhyan N Indian J Pediatr; 2018 Oct; 85(10):836-840. PubMed ID: 29441456 [TBL] [Abstract][Full Text] [Related]
10. Medical treatment of patients with infantile spasms. Mikati MA; Lepejian GA; Holmes GL Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients. Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998 [TBL] [Abstract][Full Text] [Related]
12. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms. Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640 [TBL] [Abstract][Full Text] [Related]
14. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex. Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562 [TBL] [Abstract][Full Text] [Related]
15. Adrenocorticotropic hormone for the treatment of West Syndrome in children. Shumiloff NA; Lam WM; Manasco KB Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552 [TBL] [Abstract][Full Text] [Related]
16. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective. Ibrahim S; Gulab S; Ishaque S; Saleem T BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871 [TBL] [Abstract][Full Text] [Related]
18. The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study. O'Callaghan FJ; Lux AL; Darke K; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; Verity CM; Osborne JP Epilepsia; 2011 Jul; 52(7):1359-64. PubMed ID: 21668442 [TBL] [Abstract][Full Text] [Related]
19. Infantile spasms. Wong M; Trevathan E Pediatr Neurol; 2001 Feb; 24(2):89-98. PubMed ID: 11275456 [TBL] [Abstract][Full Text] [Related]
20. Drug-choice in management of West syndrome (infantile spasms): Early ACTH treatment may offer a better prognostic outcome. Jaseja H Med Hypotheses; 2008; 70(1):197-8. PubMed ID: 17590279 [No Abstract] [Full Text] [Related] [Next] [New Search]